Delivering Tomorrow’s Medicines Today
Cryoport provides critical support for today’s biopharma industry
Featured
-
-
Breaking News | Industry News
Wasdell Group Receives IMP License for European HQ
Enables Wasdell to expand the facility’s services.Contract Pharma Staff 05.29.20
-
Breaking News | Industry News | Packaging & Tracking | Supply Chain
TraceLink Introduces Issue Management Solution
Enables companies to collaboratively identify, document and resolve supply chain issues.Contract Pharma Staff 05.29.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Gilead and Arcus Ink $2B Cancer Partnership
To co-develop and co-commercialize next-generation cancer immunotherapiesContract Pharma Staff 05.29.20
-
Facilities | Information Technology
Prepare Your Facility for a Pandemic – How Data Can Help
Data is being used to monitor and reduce the impact of the virus, and to allocate resources and anticipate needs.David Keith, Director of Strategic Facility Planning, CRB 05.29.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CordenPharma & Moderna Extend Manufacturing Agreement
For the supply of lipid excipients to be used in Moderna's coronavirus vaccineContract Pharma Staff 05.29.20
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Labcorp Accelerates Adoption of Decentralized Clinical Trials
Expands technology ecosystem through alliance with MedableContract Pharma Staff 05.29.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax
AAVCOVID, being developed by U.S. researchers in Massachusetts, leverages adeno-associated viral vector technology to produce immunity.Contract Pharma Staff 05.28.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.Contract Pharma Staff 05.28.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Roche Initiates Phase III Trial in COVID-19 Pneumonia
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.Contract Pharma Staff 05.28.20
-
Analytical Services | Breaking News | Clinical Trial Materials | Industry News
Almac Receives Grant to Support COVID-19 Studies
Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.Contract Pharma Staff 05.28.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Drug Development | Process Development
Arranta Bio Expands Microbiome Capacity at CoE
Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.Contract Pharma Staff 05.28.20
-
Packaging & Tracking
Contract Packaging Demand Amid COVID-19
Nic Hunt of Jones Healthcare Group discusses the pharmaceutical industry’s changing needs.Online Exclusives Kristin Brooks, Contract Pharma 05.28.20
-
Bioanalytical Services | Drug Discovery | Industry News
Lonza, Sanquin Reagents Enter Strategic Pact
Expands Lonza’s portfolio of endotoxin testing products and enables drug developers and QC labs to leverage sustainable MAT method.Contract Pharma Staff 05.28.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Oncodesign and HitGen Enter Strategic Partnership
Aim to expand Integrated Drug Discovery Services.Contract Pharma Staff 05.27.20
- Prepare Your Facility for a Pandemic – How Data Can Help
- CordenPharma & Moderna Extend Manufacturing Agreement
- AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax
- Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax
- Roche Initiates Phase III Trial in COVID-19 Pneumonia
- Almac Receives Grant to Support COVID-19 Studies
- Contract Packaging Demand Amid COVID-19
- IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
- Merck and Ridgeback Bio Collaborate
- Ajinomoto Bio-Pharma Partners with Humanigen
- Wasdell Group Receives IMP License for European HQ
- TraceLink Introduces Issue Management Solution
- Gilead and Arcus Ink $2B Cancer Partnership
- CordenPharma & Moderna Extend Manufacturing Agreement
- Labcorp Accelerates Adoption of Decentralized Clinical Trials
- AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax
- Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax
- Roche Initiates Phase III Trial in COVID-19 Pneumonia
- Almac Receives Grant to Support COVID-19 Studies
- Arranta Bio Expands Microbiome Capacity at CoE
May 2020
- Covid 19: Impact on Bioprocessing and Outsourcing
- CEO Spotlight: Dr. Tae Han Kim
- The U.S. Biosimilars Market: Shaking the “Laggard” Label
- HPAPI Drug Manufacturing Trends
- CEO Spotlight: Larry Lee
- Expanding CMO/CDMO Roles
- FDA cGMP Inspections Amid COVID-19 Pandemic
- Healthcare Fraud Enforcement in the Era of COVID-19
- Manufacturing of Solid Dosage Forms
- Streamlining Lab Processes for Faster Antibody Discovery
Contract Service Directory
Search the Directories for A Company:
